兔抗BCL9多克隆抗體

Background:

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Applications:

ELISA, IHC

Name of antibody:

BCL9

Immunogen:

Fusion protein of human BCL9

Full name:

B-cell CLL/lymphoma 9

Synonyms:

LGS

SwissProt:

O00512

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human thyroid cancer and human cervical cancer

IHC Recommend dilution:

25-100